Role and application of early transient presence of M1 macrophages in bone tissue engineering
- VernacularTitle:早期短暂M1巨噬细胞在骨组织工程中的作用及应用
- Author:
Yuqing YANG
1
;
Zhiyu CHEN
Author Information
- Keywords: macrophage; M1; inflammatory response; bone defect; bone regeneration; tissue engineering; sequential activation; angiogenesis
- From: Chinese Journal of Tissue Engineering Research 2024;28(4):594-601
- CountryChina
- Language:Chinese
- Abstract: BACKGROUND:Early transient presence of M1 macrophages can play a beneficial role after the implantation of bone tissue engineering materials.Recently,strategies for manipulating M1 macrophages to produce an early moderate inflammatory response have been extensively studied and many research advances have been made in the design of bone tissue engineering materials. OBJECTIVE:To review the role of early transient presence of M1 macrophages in bone tissue engineering and recent research advances in the strategy for activating early transient presence of M1 macrophages in the field of bone tissue engineering. METHODS:Relevant literature included in PubMed,WanFang database,and CNKI Database from January 2012 to October 2022 was searched.Search terms were"M1,macrophage,bone immunoregulation,bone defect,osteogenesis,osteoimmunology,angiogenesis"in English and Chinese.After excluding articles irrelevant to the research purpose and repetitive articles,63 papers were finally included for review. RESULTS AND CONCLUSION:The early transient presence of M1 macrophages play a key role in bone tissue engineering by promoting angiogenesis,facilitating osteogenic differentiation of bone marrow mesenchymal stem cells and promoting an M2 macrophage phenotype.Strategies for inducing and activating early transient presence of M1 macrophages can modulate the local immune microenvironment for bone defect repair in a manner consistent with early natural bone healing,including modulation of the physicochemical properties of bone tissue engineering materials to promote appropriate M1 macrophage-mediated inflammatory responses,sequential delivery of cytokines,microRNAs or bioactive ions to facilitate the M1-to-M2 transition of macrophages,and controlled release of anti-inflammatory substances to achieve the maintenance of early inflammatory responses.
